Please Wait...

Roger Bullock

Translation skills

Main profile

Roger Bullock
Roger Bullock, MB.BS, MRCPsych
Key Opinion Leader

Roger Bullock is a licensed psychiatrist with more than 30 years of clinical experience. He is widely published in the areas of Alzheimer's disease, dementia, and memory loss, and serves as a scientific consultant for Bioclinica's Alzheimer's research studies.

Dr. Bullock completed his pre-clinical medical training at Keble College, Oxford University, gaining a BA (Hons) Physiological Sciences in 1978 (converted to MA in 1985). This was followed by clinical medical training at St Bartholomew's Hospital in London where he gained the MB.BS in 1981.

In 1990, he specialized in psychiatry, gained membership of The Royal College of Psychiatry and undertook postgraduate psychiatric training including higher specialist training in geriatric psychiatry which concluded in 1993.

Dr. Bullock is committed to research, particularly in psychopharmacology, neuropsychology, and the use of both in all areas of care. He believes that clinical trials not only benefit his current patients but will be of benefit to further patients in the future. He also feels that trials improve the service, introducing additional rigor to clinical practice.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

RT @SullyHIT: .@HIMSS writes new definition of interoperability - and seeks feedback https://t.co/p1fi4nqrsG @HealthITNews "This definition…
Bioclinica (2 days ago)
RT @DellEMCHealth: Top pharma use cases for the cloud https://t.co/mtPsdmfwXn via @HealthITNews #TransformHIT https://t.co/w14VstRwf0
Bioclinica (2 days ago)
RT @DDNewsOnline: Look into recent efforts to understand & fight #glioblastoma & #medulloblastoma Read our Spotlight on #Oncology “#Cancer…
Bioclinica (2 days ago)
Sponsors conducting clinical trials in #NAFLD or #NASH are invited to join us in an upcoming webinar exploring the… https://t.co/I19Bz8WLBa
Bioclinica (2 days ago)
RT @RAPSorg: Reorganization of @US_FDA’s Office of the Commissioner to Begin Soon | #Regulatory Focus https://t.co/9b3UshJUgD #FDA
Bioclinica (2 days ago)
RT @ACROhealth: More than 325 million people own wearable devices, making it more convenient than ever for researchers to incorporate them…
Bioclinica (2 days ago)

Latest Blogs:

Site Payments Solutions
Nonalcoholic steatohepatitis (NASH) development programs
Dr. Joby John
Transformational Trends in Investigator Site Payments
Clinical Supply Chain Success: Leveraging Technology
Blood pressure monitor
Prescription box